Gene: TMEM183A
Official Full Name: transmembrane protein 183Aprovided by HGNC
Gene Summary: Predicted to be involved in regulation of protein stability. Predicted to be located in membrane. Predicted to be part of SCF ubiquitin ligase complex. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO22669 | TMEM183A Knockout cell line (HeLa) | Human | TMEM183A | 1:3~1:6 | Negative | Online Inquiry |
KO22670 | TMEM183A Knockout cell line (HCT 116) | Human | TMEM183A | 1:2~1:4 | Negative | Online Inquiry |
KO22671 | TMEM183A Knockout cell line (HEK293) | Human | TMEM183A | 1:3~1:6 | Negative | Online Inquiry |
TMEM183A Gene Knockout Cell Lines represent a crucial advancement in the field of genetic research, offering a tailored platform for studying the functional role of the TMEM183A gene in various biological contexts. These cell lines are engineered to lack the expression of the TMEM183A gene, facilitating investigations into its involvement in cellular processes such as proliferation, differentiation, and response to external stimuli. Utilizing CRISPR-Cas9 technology for precise gene editing, these knockout models allow researchers to dissect the pathways in which TMEM183A is implicated, yielding insights that are critical for understanding its potential role in diseases.
The key function of these knockout cell lines lies in their ability to elucidate the biological significance of TMEM183A through comparative analyses with wild-type cell lines. By examining phenotypic variations, gene expression profiles, and signaling pathways altered by the absence of TMEM183A, researchers can uncover essential data related to gene function and interactions, making these cell lines invaluable tools in both basic and applied biomedical research.
The scientific importance of TMEM183A Gene Knockout Cell Lines extends to various applications, including drug discovery, disease modeling, and functional genomics. Insights garnered from these studies have the potential to inform therapeutic strategies for conditions where TMEM183A plays a role.
When compared to alternative models, our TMEM183A Gene Knockout Cell Lines offer high specificity, a reproducible 96-well assay format for high-throughput screening, and extensive validation demonstrating successful knockout efficiency. These features ensure that researchers obtain reliable and interpretable results, a critical factor in the reproducibility of experimental science.
Given their robust capabilities and ease of use, TMEM183A Gene Knockout Cell Lines are an invaluable asset for researchers and clinicians aiming to advance their understanding of gene function and contribute to innovative therapies. Our company, with its commitment to excellence in genetic engineering and cell line development, provides these specialized products backed by a team of experienced scientists dedicated to supporting the scientific community’s needs.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.